Profil bibliographique

R. Spiera

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

13Publications signalées

50Citations signalées

2Affiliations récentes

Institutions déclarées

Hospital for Special Surgery Cornell University

Domaines associés

Vasculitis and related conditionsRheumatoid Arthritis Research and TherapiesOtitis Media and Relapsing PolychondritisSystemic Sclerosis and Related DiseasesUrticaria and Related Conditions

Publications récentes

Accès ouvert 2026 article

Phase II randomised, double-blind, placebo-controlled, dose-ranging study of nemolizumab with an extension period in adult patients with systemic sclerosis: THESSALIA study design and rationale

Oliver Distler, Dinesh Khanna, R. Spiera, Johann E Gudjonsson et autres

0 citationsJournal of Scleroderma and Related Disorders

2026 article

A phase 2 trial of rilzabrutinib in IgG4-related disease

John H. Stone, Mollie Carruthers, Matthew C Baker, Alireza Meysami et autres

0 citationsAnnals of the Rheumatic Diseases

2026 article

Phase 3 Trial of Secukinumab in Polymyalgia Rheumatica

John H. Stone, Frank Buttgereit, Alain Saraux, Wolfgang A. Schmidt et autres

4 citationsNew England Journal of Medicine

Accès ouvert 2026 article

Secukinumab for Giant Cell Arteritis

John H. Stone, Nils Venhoff, Frank Buttgereit, Christian Dejaco et autres

4 citationsNEJM Evidence

2026 article

Secukinumab chez des patients atteints de pseudopolyarthrite rhizomélique : résultats à la semaine 52 d’un essai de phase 3, multicentrique, randomisé, en double aveugle, contrôlé par placebo (REPLENISH)

J. Stone, F. Buttgereit, A. Saraux, W. A. Schmidt et autres

0 citationsLa Revue de Médecine Interne

Accès ouvert 2026 conference-paper

P.282 Impact of updated treatment paradigms on clinical trial referral in diffuse cutaneous systemic sclerosis

Kimberly Lakin, R. Spiera, Antonia Valenzuela, Deanna Jannat-Khah et autres

0 citationsPoster presentations

2025 conference-abstract

Real-world Treatment Patterns in Patients With Eosinophilic Granulomatosis With Polyangiitis (EGPA)

Stephanie Chen, R. Spiera, Bo Ding, A. Shavit et autres

0 citationsAmerican Journal of Respiratory and Critical Care Medicine

2024 conference-abstract

OP0174 AVACOPAN VERSUS PREDNISONE TAPER IN PATIENTS WITH ANCA-ASSOCIATED VASCULITIS AND EAR, NOSE, OR THROAT INVOLVEMENT

R. Spiera, Robert S. Lebovics, Sarah Bray, Rachel E Gurlin et autres

0 citationsAnnals of the Rheumatic Diseases

Accès ouvert 2023 conference-abstract

POS0715 SUSTAINED REMISSION FROM WEEKS 16 TO 52 AND WEEKS 24 TO 52 IN PATIENTS TREATED WITH SARILUMAB: POST-HOC ANALYSIS OF SAPHYR TRIAL IN PATIENTS WITH POLYMYALGIA RHEUMATICA

Bhaskar Dasgupta, Amy Praestgaard, Stefano Fiore, K. Ford et autres

0 citationsAnnals of the Rheumatic Diseases

Accès ouvert 2018 conference-abstract

SAT0531 Acute phase reactant levels and prednisone doses at disease flare in patients with giant cell arteritis: prospective data from the giacta trial

John H. Stone, Katie Tuckwell, Sophie Dimonaco, Micki Klearman et autres

2 citationsAnnals of the Rheumatic Diseases

Accès ouvert 2017 conference-abstract

THU0301 Safety following initiation of rituximab in granulomatosis with polyangiitis (GPA) or microscopic polyangiitis (MPA): interim analysis of the rituximab in anca-associated vasculitis registry (RAVER)

John L. Niles, NancyB. Allen, Joel A. Block, CL Koening et autres

3 citationsAnnals of the Rheumatic Diseases

2015 article

Imatinib mesylate (Gleevec) in the treatment of diffuse cutaneous systemic sclerosis: results of a 24-month open label, extension phase, single-centre trial.

Jessica Gordon, Uzunma Udeh, Kamini Doobay, Cynthia M. Magro et autres

33 citationsPubMed

Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Métadonnées interrogées à la demande auprès de OpenAlex (CC0). Sources et limites.